B Osterwalder

7.1k citations
73 papers · 4.7k indexed · 2 hit papers · h-index 24
  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies 16
    • Cancer Treatment and Pharmacology 16
    • Cancer Immunotherapy and Biomarkers 5
  • Dermatology top 0.5%
    • Chemotherapy-related skin toxicity 6
  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation 21
    • Acute Myeloid Leukemia Research 5
    • Blood groups and transfusion 5
  • Hepatology top 2%
    • Transplantation: Methods and Outcomes 5

B Osterwalder

70 papers receiving 4.5k citations

Hit Papers

Comparison of Oral Capecitabine Versus Intravenous Fluoro...8821999202620082017250500750

Peers

B Osterwalder
Comparison fields: 5 of 109
  • Oncology 3.8k
  • Dermatology 830
  • Hematology 571
  • Cancer Research 700
  • Hepatology 317
Replace Jeffrey Crawford with:
Jeffrey Crawford United States
P. Kosmidis Greece
Michael A. Savin United States
Shenhong Wu United States
Ullrich Graeven Germany
John Grous United States
Paul S. Ritch United States
Teresa Gamucci Italy
Th. Wobbes Netherlands
Antoinette J. Wozniak United States
B Osterwalder relative to Jeffrey Crawford United States Jeffrey Crawford's profile →
Citations per field
00.5×3.8×
Jeffrey Crawford · 1×
Citations per year

Countries citing papers authored by B Osterwalder

Since Specialization
Citations

This map shows the geographic impact of B Osterwalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Osterwalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Osterwalder more than expected).

Fields of papers citing papers by B Osterwalder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Osterwalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Osterwalder. The network helps show where B Osterwalder may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B Osterwalder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B Osterwalder Line = papers co-authored together B Osterwalder links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200937
2 20099
3 20076
4 200264
5 2002422
6 2001258
7 200122
8 1998224
9 1998221
10 19973
11 19964
12 199510
13 19917
14
[Bacillus subtilis infections].
19883
15 19883
16 198714
17 198619
18 198314
19
[Bone marrow transplantation in acute lymphatic leukemia during the first remission].
19831
20 198226

About B Osterwalder

B Osterwalder is a scholar working on Hematology, Oncology and Genetics, having authored 73 papers that have together received 4.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (21 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer Treatment and Pharmacology (16 papers), Chemotherapy-related skin toxicity (6 papers), Transplantation: Methods and Outcomes (5 papers), Acute Myeloid Leukemia Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Blood groups and transfusion (5 papers). The work is most often cited by research in Oncology (3.8k citations), Dermatology (830 citations) and Hematology (571 citations). B Osterwalder has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include T. Griffin, Aman U. Buzdar, Hans Ulrich Burger, Chris Twelves, Stephen E. Jones, Jean A. Maroun, Paulo M. Hoff, Walter Kocha, Bruno Reigner and Joanne L. Blum. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Cancer Research, European Journal of Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026